Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Spirulina Canada is a biotechnology and agricultural company specializing in the sustainable indoor cultivation of Arthrospira platensis, commonly known as spirulina. Based in Ontario, the company utilizes controlled environment agriculture (CEA) to produce high-purity spirulina that is free from heavy metals and environmental contaminants often found in outdoor-grown imports. Their product line features fresh-frozen spirulina, dried nibs, and powders, designed to maintain the maximum bioavailability of proteins, vitamins, and antioxidants like phycocyanin. By focusing on local production and minimal processing, the company provides a nutrient-dense functional food for the health and wellness market. Spirulina Canada serves both individual consumers and the broader food industry seeking high-quality plant-based protein sources.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Spirulina Canada.